Pfizer Inc (PFE)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, it appears that the days of sales outstanding (DSO) for Pfizer Inc are not specified for the years ending on December 31, 2020, 2021, 2022, 2023, and 2024. This lack of specific information on DSO makes it challenging to assess the efficiency of Pfizer's accounts receivable management and how quickly the company is able to collect outstanding sales revenue from its customers. Analyzing DSO would typically involve comparing this metric to historical data, industry benchmarks, and company targets to evaluate Pfizer's effectiveness in managing its receivables and maintaining healthy cash flows. To gain a better understanding of Pfizer's DSO trend and performance, it would be necessary to have the actual DSO values for the specified years.
Peer comparison
Dec 31, 2024